Dhanapalan Nagarathnam

USPTO Granted Patents = 61 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 5.0

ph-index = 19

Forward Citations = 1,235(Granted Patents)

Inventors with similar research interests:

Location History:

Ramsey, NJ (US) (1998 - 2004)
La Chaux-de-Fonds, CH (2015 - 2021)
Bethany, CT (US) (2001 - 2023)

Company Filing History:

20 out of 126

Synaptic Pharmaceutical Corporation

patents

14 out of 79

Gilead Pharmasset LLC

patents

14 out of 51

Rhizen Pharmaceuticals Sa

patents

4. 5 out of 70

Bayer Pharmaceuticals Corporation

Gilead Sciences, Inc.

patents

7. 1 out of 1

Gilead Pharmassel LLC

patent

8. 1 out of 2,198

Smithkline Beecham Corporation

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12121529 - Nucleoside phosphoramidate prodrugs (2024-10-22),

2. 11642361 - Nucleoside phosphoramidate prodrugs (2023-05-09),

3. 11066402 - 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases (2021-07-20),

4. 11020399 - Intermediates useful in the synthesis of compounds as modulators of protein kinases (2021-06-01),

5. 10981919 - Selective PI3K delta inhibitors (2021-04-20),

6. 10570142 - Selective PI3K delta inhibitors (2020-02-25),

7. 10322130 - Substituted chromenones as modulators of protein kinases (2019-06-18),

8. 10220035 - Compounds as modulators of protein kinases (2019-03-05),

9. 10183037 - Nucleoside phosphoramidate prodrugs (2019-01-22),

10. 10072013 - Selective PI3K delta inhibitors (2018-09-11),

11. 9815831 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases (2017-11-14),

12. 9777018 - Compounds as modulators of GPR-119 (2017-10-03),

13. 9775841 - Compounds as modulators of protein kinases (2017-10-03),

14. 9669033 - Selective PI3K delta inhibitors (2017-06-06),

15. 9585906 - Nucleoside phosphoramidate prodrugs (2017-03-07),

Title: The Innovative Journey of Dhanapalan Nagarathnam

Introduction: Dhanapalan Nagarathnam, a talented inventor based in Bethany, CT (US), has made significant contributions to the field of innovations with his creative mindset and dedication.

Latest Patents: Dhanapalan Nagarathnam holds several patents in various technological areas, showcasing his versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout his career, Dhanapalan Nagarathnam has demonstrated a passion for pushing the boundaries of what is possible through his inventions. His commitment to excellence and forward-thinking approach have led to the development of groundbreaking technologies.

Collaborations: Dhanapalan Nagarathnam has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Dhanapalan Nagarathnam's innovative spirit and relentless pursuit of excellence have established him as a prominent figure in the world of inventions. His contributions continue to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.